Inhalers currently prescribed in West Suffolk Linda Lord
Inhalers currently prescribed in West Suffolk Linda Lord, Chief Pharmacist WSCCG 1
WSCCG Prescribing Data 1. Background • Top therapeutic areas • Top drugs 2. Inhaled corticosteroids (ICS) • Asthma and COPD combined 3. WSCCG data on inhalers 4. Practice data on inhalers 2
Background: Top therapeutic areas by spend Rank BNF Subparagraph 12 -month spend (March 16 – Feb 17) 1 2 3 3 Corticosteroid (respiratory) Control of epilepsy Opioid analgesics £ 3, 539, 949 £ 2, 818, 893 £ 1, 672, 493
Background: Top drugs by spend Rank Drug 12 -month spend (March 16 – Feb 17) 1 Pregabalin £ 962, 268 2 Tiotropium (Spiriva) £ 820, 761 3 Pregabalin (Lyrica) £ 753, 569 4 Beclometasone/formoterol MDI (Fostair) Insulin Aspart (Novorapid) £ 730, 215 Budesonide/formoterol (Symbicort Turbohaler) £ 544, 638 5 6 4 £ 697, 213
ICS - WSCCG vs National 5
ICS - spend per 1000 patients (Feb 2017) CCG spending most 6 WSCCG National CCG spending least
ICS - Spend/10, 000 patients in practices (Feb 2017) 7
Inhalers - WSCCG March 16 – Feb 17 • Total spend on all inhalers: £ 4. 6 m • Total spend on COPD inhalers: £ 1. 4 m • % (by cost) of COPD inhalers ‘in formulary’ varies by practice Average = 66% 8
Inhalers - Practice Packs • e. PACT prescribing data, latest 12 months • Information on COPD inhalers and all inhalers • Tool to promote best practice and improve cost effective prescribing • Which inhalers are prescribed at your practice? • Is there excessive prescribing of ICS for COPD at your practice? • Is there excessive prescribing of bronchodilators at your practice? • Are your COPD inhalers in-formulary or offformulary? 9
- Slides: 9